Age-related macular degeneration: pathophysiology, management, and future perspectives
Among older adults, age-related macular degeneration (AMD) is a prevalent disabling
condition that begins as subtle visual disturbances and can progress to permanent loss of …
condition that begins as subtle visual disturbances and can progress to permanent loss of …
[HTML][HTML] Global burden of dry age-related macular degeneration: a targeted literature review
NM Schultz, S Bhardwaj, C Barclay, L Gaspar… - Clinical …, 2021 - Elsevier
Purpose Age-related macular degeneration (AMD) is a leading cause of blindness,
particularly in higher-income countries. Although dry AMD accounts for 85% to 90% of AMD …
particularly in higher-income countries. Although dry AMD accounts for 85% to 90% of AMD …
Prevalence of age-related macular degeneration in the US in 2019
DB Rein, JS Wittenborn, Z Burke-Conte… - JAMA …, 2022 - jamanetwork.com
Importance Age-related macular degeneration (AMD) is a leading cause of vision loss and
blindness. AMD prevalence has not been estimated for the US in over a decade and early …
blindness. AMD prevalence has not been estimated for the US in over a decade and early …
Fives: A fundus image dataset for artificial Intelligence based vessel segmentation
Retinal vasculature provides an opportunity for direct observation of vessel morphology,
which is linked to multiple clinical conditions. However, objective and quantitative …
which is linked to multiple clinical conditions. However, objective and quantitative …
Safety outcomes of brolucizumab in neovascular age-related macular degeneration: results from the IRIS Registry and Komodo Healthcare Map
AM Khanani, MA Zarbin, MR Barakat… - JAMA …, 2022 - jamanetwork.com
Importance Limited data exist on the real-world safety outcomes of patients with neovascular
age-related macular degeneration treated with brolucizumab (Beovu). Objective To …
age-related macular degeneration treated with brolucizumab (Beovu). Objective To …
A linkage between angiogenesis and inflammation in neovascular age-related macular degeneration
H Heloterä, K Kaarniranta - Cells, 2022 - mdpi.com
Age-related macular degeneration (AMD) is the leading cause of visual impairment in the
aging population with a limited understanding of its pathogenesis and the number of …
aging population with a limited understanding of its pathogenesis and the number of …
Effect of high-dose intravitreal aflibercept, 8 mg, in patients with neovascular age-related macular degeneration: the phase 2 CANDELA randomized clinical trial
Importance Aflibercept, 8 mg, may have greater therapeutic benefits compared with
aflibercept, 2 mg, in patients with neovascular age-related macular degeneration (nAMD) …
aflibercept, 2 mg, in patients with neovascular age-related macular degeneration (nAMD) …
A multimodal deep learning system to distinguish late stages of AMD and to compare expert vs. AI ocular biomarkers
Abstract Within the next 1.5 decades, 1 in 7 US adults is anticipated to suffer from age-
related macular degeneration (AMD), a degenerative retinal disease which leads to …
related macular degeneration (AMD), a degenerative retinal disease which leads to …
Retinal specialist versus artificial intelligence detection of retinal fluid from OCT: age-related eye disease study 2: 10-year follow-on study
Purpose To evaluate the performance of retinal specialists in detecting retinal fluid presence
in spectral domain OCT (SD-OCT) scans from eyes with age-related macular degeneration …
in spectral domain OCT (SD-OCT) scans from eyes with age-related macular degeneration …
Mechanisms of macular edema
CD Haydinger, LB Ferreira, KA Williams… - Frontiers in …, 2023 - frontiersin.org
Macular edema is the pathological accumulation of fluid in the central retina. It is a
complication of many retinal diseases, including diabetic retinopathy, retinal vascular …
complication of many retinal diseases, including diabetic retinopathy, retinal vascular …